Valeria Fantin
About Valeria Fantin
Valeria Fantin serves as the Chief Strategy Officer at Zai Lab and Oric Pharmaceuticals, bringing extensive experience in the pharmaceutical industry, including roles at Pfizer, Agios Pharmaceuticals, and Merck.
Work at ORIC Pharmaceuticals
Valeria Fantin has served as the Chief Strategy Officer at ORIC Pharmaceuticals since 2015. In this role, she has been instrumental in shaping the strategic direction of the company. ORIC Pharmaceuticals focuses on developing innovative therapies for cancer treatment, and Fantin's leadership contributes to the company's mission of addressing unmet medical needs in oncology. Her tenure at ORIC has spanned over nine years, during which she has leveraged her extensive background in pharmaceutical research and development.
Current Role at Zai Lab
In addition to her role at ORIC Pharmaceuticals, Valeria Fantin has been the Chief Strategy Officer at Zai Lab since 2019. Based in Pudong, Shanghai, China, she plays a critical role in guiding the company's strategic initiatives. Zai Lab is known for its focus on innovative medicines for cancer and autoimmune diseases, and Fantin's expertise supports the company's growth and development in these therapeutic areas.
Previous Experience at Ariad Pharmaceuticals
Valeria Fantin worked as a Principal Scientist at Ariad Pharmaceuticals, Inc. in 2008 for a duration of seven months. During her time in Cambridge, Massachusetts, she contributed to research efforts aimed at advancing cancer therapies. This role provided her with valuable experience in the pharmaceutical industry and further developed her expertise in oncology.
Education and Expertise
Valeria Fantin holds a PhD from the Geisel School of Medicine at Dartmouth, which she completed from 1996 to 1999. She furthered her education with a post-doctoral fellowship at Harvard Medical School from 2000 to 2004. Her academic background has equipped her with a strong foundation in medical research, particularly in the field of oncology, which has been central to her career in the pharmaceutical industry.
Career Progression and Roles
Throughout her career, Valeria Fantin has held several significant positions in the pharmaceutical industry. She served as Senior Scientist at Merck from 2004 to 2008, followed by her role as Senior Director of Molecular Oncology at Agios Pharmaceuticals from 2009 to 2011. She then became Vice President of Tumor Cell Biology at Pfizer, where she worked from 2011 to 2015. This progression highlights her extensive experience and leadership in oncology research and development.